Indication

Plasmodium falciparum malaria

Plasmodium falciparum malaria is a life-threatening protozoan infection primarily transmitted to humans by the bite of an infected female *Anopheles* mosquito. Read more about Plasmodium falciparum malaria

69 drugs 52 manufacturers

Advertisement

Drugs that treat it

Common Plasmodium falciparum malaria therapies.

Showing 37–45 of 69 drugs

CHLOROQUINE PHOSPHATE

ANTIRHEUMATIC AGENTS (DMARDS, NON-BIOLOGIC)·PLASMODIUM FALCIPARUM MALARIA·+4
AVKARE
Filter & compare in the drug finder →Opens the drug finder with Plasmodium falciparum malaria preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Plasmodium falciparum malaria.

Plasmodium falciparum malaria is a life-threatening protozoan infection primarily transmitted to humans by the bite of an infected female *Anopheles* mosquito.

The pathogen targets the hepatic and hematologic systems, where asexual replication within erythrocytes leads to widespread red blood cell destruction and systemic inflammation.

Pathophysiologically, mature infected erythrocytes express surface adhesion ligands that promote cytoadherence and vascular sequestration within microcapillary beds, predisposing patients to profound microvascular obstruction, severe anemia, metabolic acidosis, acute respiratory distress, and cerebral malaria.

While young children, pregnant individuals, and non-immune travelers bear the greatest risk of rapidly progressive, fatal disease, the infection remains a critical global threat across all exposed populations.

Personalize your experience

Follow Plasmodium falciparum malaria and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it